Cefaly is an FDA-cleared OTC headband device using external trigeminal nerve stimulation to treat and prevent migraine.
Cefaly is a headband wearable delivering external trigeminal nerve stimulation through a forehead electrode. It is FDA-cleared for acute treatment of migraine attacks and for prevention.
Available without a prescription, it offers a 60-minute acute mode and a 20-minute daily prevention session. A companion app supports control and tracking, and purchases are HSA/FSA eligible.
Adds products that compete with one of Cefaly’s direct competitors but not with Cefaly itself. They are shaded, and Linked Through names the direct competitor each one competes with.
| Attribute | Cefaly | Vestibular Migraine Treatment Wearable | gammaCore | Nerivio | |
|---|---|---|---|---|---|
| Linked Through | — | Direct competitor | Vestibular Migraine Treatment Wearable | Vestibular Migraine Treatment Wearable | |
| Provider |  |  |  |  | |
| Founded | 2004 | 2015 | 2005 | 2016 | |
| Sells To | Consumers | Consumers | B2G | Patients | |
| Pricing Model | E-commerce | Recurring | Recurring, Transactional | — | |
| Ownership | Private | Venture-backed | Public | Private |
Provider
Founded 2004
Sells To Consumers
Pricing Model E-commerce
Ownership Private
Provider
Founded 2015
Sells To Consumers
Pricing Model Recurring
Ownership Venture-backed
Linked Through Vestibular Migraine Treatment Wearable
Provider
Founded 2005
Sells To B2G
Pricing Model Recurring, Transactional
Ownership Public
Linked Through Vestibular Migraine Treatment Wearable
Provider
Founded 2016
Sells To Patients
Pricing Model —
Ownership Private
gammaCore is a prescription non-invasive vagus nerve stimulation device for treating cluster headaches and migraine.
Nerivio is an FDA-cleared prescription armband wearable using remote electrical neuromodulation to treat and prevent migraine.
gammaCore is a prescription non-invasive vagus nerve stimulation device for treating cluster headaches and migraine.